Value through Innovation17 January 2013
Corporate Profile
  • Home
  • Search Result

Page content

jump to main navigation jump to meta navigation

Your search results.

  1. Dr Joachim Hasenmaier, Boehringer Ingelheim GmbH

    Dr Joachim Hasenmaier, Boehringer Ingelheim GmbH, Corporate Board Divisions Animal Health and Consumer Healthcare (CHC)

    • Size: 6 kB
    • Last Update: 12.11.2012

  2. 28 June 2012 Diabetes

    New publication in The Lancet: Two-year study in over 1,500 patients compares Trajenta® (linagliptin) to the commonly prescribed sulphonylurea glimepiride

    • Size: 11 kB
    • Last Update: 31.10.2012

  3. Dr Joachim Hasenmaier, Boehringer Ingelheim GmbH

    Dr Joachim Hasenmaier, Boehringer Ingelheim GmbH, Corporate Board Divisions Animal Health and Consumer Healthcare (CHC)

    • Size: 22 kB
    • Last Update: 12.11.2012

  4. 09 July 2012 Translational Research Collaboration

    Boehringer Ingelheim Establishes Translational Research Collaboration with Harvard University in Areas of Unmet Medical Need

    • Size: 6 kB
    • Last Update: 5.11.2012

  5. Engelbert Tjeenk Willink

    Engelbert Tjeenk Willink, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales

    • Size: 2 MB
    • Last Update: 12.11.2012

  6. Engelbert Tjeenk Willink

    Engelbert Tjeenk Willink, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales

    • Size: 6 kB
    • Last Update: 12.11.2012

  7. 23 July 2012 FXT

    Boehringer Ingelheim and Funxional Therapeutics announce acquisition of Funxional’s FX125L and the somatotaxin portfolio to treat inflammation

    • Size: 7 kB
    • Last Update: 5.11.2012

  8. Engelbert Tjeenk Willink

    Engelbert Tjeenk Willink, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales

    • Size: 7 kB
    • Last Update: 12.11.2012

  9. 16 February 2011 Porcine

    Clinical disease associated with PCV2 infection is not a major issue nowadays as pigs can be protected very effectively by vaccination, and piglet vaccination has become routine use worldwide.

    • Size: 8 kB
    • Last Update: 5.11.2012

  10. Prof. Dr Dr Andreas Barner

    Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine

    • Size: 6 kB
    • Last Update: 12.11.2012
back to top